A checkpoint on innate myeloid cells in pulmonary arterial hypertension
Open Access
- 1 January 2019
- journal article
- research article
- Published by Wiley in Pulmonary Circulation
- Vol. 9 (1) , 1-5
Abstract
No abstract availableFunding Information
- National Heart, Lung, and Blood Institute (R01 HL136748, P01 HL108800, K08 HL144085)
This publication has 21 references indexed in Scilit:
- A new procedure to analyze polymorphonuclear myeloid derived suppressor cells in cryopreserved samples cells by flow cytometryPLOS ONE, 2018
- Myeloid-derived Suppressor Cells Are Necessary for Development of Pulmonary HypertensionAmerican Journal of Respiratory Cell and Molecular Biology, 2018
- The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertensionEuropean Respiratory Journal, 2018
- Hypoxia-induced PD-L1/PD-1 crosstalk impairs T-cell function in sleep apnoeaEuropean Respiratory Journal, 2017
- Alpha-1 Antitrypsin-Deficient Macrophages Have Increased Matriptase-Mediated Proteolytic ActivityAmerican Journal of Respiratory Cell and Molecular Biology, 2017
- Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependentScience, 2017
- Endothelial HIF signaling regulates pulmonary fibrosis-associated pulmonary hypertensionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2016
- Peripheral Blood Signature of Vasodilator-Responsive Pulmonary Arterial HypertensionCirculation, 2015
- Circulating Myeloid-Derived Suppressor Cells Are Increased and Activated in Pulmonary HypertensionChest, 2012
- Bone morphogenetic protein receptor II regulates pulmonary artery endothelial cell barrier functionBlood, 2011